A.P. Pharma to Present at OneMedForum 2012 Financial Conference

REDWOOD CITY, CA, Jan 06, 2012 (MARKETWIRE via COMTEX) –
A.P. Pharma, Inc.


/quotes/zigman/7850385 APPA
+4.17%



, a specialty pharmaceutical
company, today announced that the Company will present at the
OneMedForum San Francisco 2012 Finance Conference on January 11, 2012
at 10:45 a.m. PST. The conference will be held at the Sir Francis
Drake Hotel in San Francisco. A.P. Pharma management will provide an
overview of recent corporate progress.

About A.P. Pharma

A.P. Pharma is a specialty pharmaceutical company developing products
using its proprietary Biochronomer(TM) polymer-based drug delivery
technology. The Company’s primary focus is on its lead product,
APF530, for the prevention of chemotherapy-induced nausea and
vomiting (CINV). A.P. Pharma received a Complete Response Letter on
the APF530 New Drug Application (NDA) and is targeting the
resubmission of the NDA for the first half of 2012. The Company has
additional clinical and preclinical stage programs in the area of
pain management, all of which utilize its bioerodible, injectable and
implantable delivery systems. For further information, please visit
the Company’s web site at
www.appharma.com .

Forward-looking Statements

This news release contains “forward-looking statements” as defined by
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements involve risks and uncertainties, including
uncertainties associated with capital resources and liquidity, timely
development and regulatory approval of product candidates,
satisfactory completion of clinical studies, progress in research and
development programs, launch and acceptance of new products and other
risks and uncertainties identified in the Company’s filings with the
Securities and Exchange Commission. We caution investors that
forward-looking statements reflect our analysis only on their stated
date. We do not intend to update them except as required by law.

        Investor Relations Contact:
        Mike Rice
        Office Phone: (646) 597-6979
        Mobile Phone: (917) 282-3242
        Email: mrice@lifesciadvisors.com

        Corporate Contact:
        A.P. Pharma, Inc.
        John B. Whelan
        President, Chief Executive Officer and Chief Financial Officer
        650-366-2626

SOURCE: A.P. Pharma, Inc.

        mailto:mrice@lifesciadvisors.com

Copyright 2012 Marketwire, Inc., All rights reserved.

/quotes/zigman/7850385

Add APPA to portfolio

APPA